Diurnal Group PLC (LON:DNL) fell 3.5% on Thursday . The stock traded as low as GBX 26.55 ($0.35) and last traded at GBX 26.55 ($0.35), 20,000 shares changed hands during trading. An increase of 169% from the average session volume of 7,428 shares. The stock had previously closed at GBX 27.50 ($0.36).
The company has a fifty day moving average of GBX 31.58 and a two-hundred day moving average of GBX 30.86. The company has a market cap of $23.28 million and a price-to-earnings ratio of -1.40.
In related news, insider Martin Whitaker sold 44,810 shares of the firm’s stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of GBX 37 ($0.48), for a total value of £16,579.70 ($21,664.31).
Diurnal Group Company Profile (LON:DNL)
Diurnal Group plc operates as a specialty pharma company. The company develops hormone therapeutics for the treatment of chronic endocrine conditions, including congenital adrenal hyperplasia, adrenal insufficiency, hypogonadism, and hypothyroidism. Its product pipeline includes Infacort for use in children suffering from adrenal insufficiency; and Chronocort, which completed Phase III clinical trials targeting congenital adrenal hyperplasia in adult patients, as well as adrenal insufficiency.
See Also: What is a stock split?
Receive News & Ratings for Diurnal Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diurnal Group and related companies with MarketBeat.com's FREE daily email newsletter.